Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000466650 | SCV000548549 | benign | Acute myeloid leukemia | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258908 | SCV002531735 | likely benign | Hereditary cancer-predisposing syndrome | 2020-12-03 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV004609385 | SCV005105505 | likely benign | Inborn genetic diseases | 2024-03-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genomic Diagnostics Laboratory, |
RCV000466650 | SCV002104198 | likely pathogenic | Acute myeloid leukemia | flagged submission | clinical testing | The variant was detected in bone marrow from patients, but it was not confirmed in the matched |